1. Home
  2. POAS vs NXTS Comparison

POAS vs NXTS Comparison

Compare POAS & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$0.17

Market Cap

4.6M

Sector

Industrials

ML Signal

N/A

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$1.91

Market Cap

5.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
POAS
NXTS
Founded
2017
2009
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Agricultural Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
5.3M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
POAS
NXTS
Price
$0.17
$1.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
261.0K
49.8K
Earning Date
05-21-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$263,445.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.55
52 Week High
$7.40
$23.80

Technical Indicators

Market Signals
Indicator
POAS
NXTS
Relative Strength Index (RSI) 29.50 39.62
Support Level N/A $1.43
Resistance Level $0.39 $2.16
Average True Range (ATR) 0.03 0.22
MACD 0.01 0.12
Stochastic Oscillator 14.35 54.79

Price Performance

Historical Comparison
POAS
NXTS

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: